Trust CO Viatris Inc Transaction History

Trust CO

$821 Million
Q3 2024

A detailed history of Trust CO transactions in Viatris Inc stock. As of the latest transaction made, Trust CO holds 37 shares of VTRS stock, worth $458. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 37 -0.0%

Holding current value

$458

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 15, 2024	SELL	$10.05 - $12.02 $643 - $769	-64 Reduced 63.37%	37 $0
Q3 2023 Dec 04, 2023	BUY	$9.59 - $11.35 $354 - $419	37 Added 57.81%	101 $0
Q2 2023 Jul 10, 2023	BUY	$9.02 - $10.29 $577 - $658	64 New	64 $0

Others Institutions Holding VTRS

# of Institutions

1,102

Shares Held

933M

Call Options Held

2.71M

Put Options Held

2.4M

Vanguard Group Inc Valley Forge, PA

141M
Shares

$1.75 Billion
0.03% of portfolio
Black Rock Inc. New York, NY

92.7M
Shares

$1.15 Billion
0.02% of portfolio
State Street Corp Boston, MA

63.1M
Shares

$783 Million
0.03% of portfolio
Chris Davis Davis Selected Advisers | Tucson, Az

62.6M
Shares

$777 Million
4.18% of portfolio
Price T Rowe Associates Inc Baltimore, MD

48.8M
Shares

$605 Million
0.07% of portfolio

View Full List

About Viatris Inc

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $15B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

More about VTRS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Trust CO with notifications on news.

Account